Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Tech and Defense sectors.

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

In a sweeping push for transparency and consumer safety, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy has directed the Food and Drug Administration (FDA) to close a decades-old ...

It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...

In response, Cogito Tech has launched DataSum, a certification framework designed to make AI data sourcing more transparent ...

"That label doesn't mean they don't add any at all." Shopper puzzled by misleading ingredients label while examining ...

Markary, a surgeon at Johns Hopkins, gave safe, vague and polished answers to senators' questions on mifepristone and the cancellation of an FDA vaccine committee meeting.

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

A patient's court battle for affordable SMA treatment highlights the need for policy implementation and transparent drug pricing.